CTRI/2024/02/062972尚未招募Unknown
An Open-Label, Non-Randomized, Single-Arm, Single-Centre, Prospective, Interventional, Safety, Efficacy and Tolerability Study of Hair Growth and Anti-Gray Hair Serum in Healthy Adult Females with Partially Gray Hairs and Hair Fall Complaints. - Nil
Soulflower PT INVENT INDIA PVT LTD0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1)Age: 20 to 55 years (both inclusive) at the time of consent.
- •2)Sex: Healthy non-pregnant/non-lactating females.
- •3)Females of childbearing potential must have a self-reported negative pregnancy test.
- •4)Subject are generally in good health.
- •5)Subject with partially gray hair.
- •6)Subject with low hair growth and complaint of hair fall.
- •7)Subject with self-assessed complaint of thinning of hair.
- •8)Subject is able to remain on stable doses of contraceptive or replacement hormonal therapy, including no therapy, 6 weeks prior to and for the duration of the study.
- •9)If the subject is of childbearing potential, is practicing and agrees to maintain an established method of birth control (IUD, hormonal implant device/injection, regular use of birth control pills or patch, diaphragm, condoms with spermicide or sponge with spermicidal jelly, cream or foam, partner vasectomy or abstinence). Females will be considered as non-childbearing potential if they are surgically sterile, have been post-menopausal for at least 1 year or have had a tubal ligation.
- •10)If currently using hormonal contraception, has been using this form of contraception for at least 6 months and agrees to continue using the same contraception for the duration of the study.
- •11)Subjects are willing to give written informed consent and are willing to follow the study procedure.
- •12)Subjects who commit not to use medicated/ prescription shampoos/hair care products (containing Minoxidil), any other hair growth hair products or hair colour or dye, other than the test products for the entire duration of the study.
- •13)Willing to use test product throughout the study period.
排除标准
- •1)Subjects with any other hair colour except gray.
- •2)History of any dermatological condition of the scalp other than hair loss and/or dandruff.
- •3)History of prior use of hair growth treatment within 3 months.
- •4)History of any prior hair growth procedures (e.g., hair transplant or laser).
- •5)Subjects who have applied topical treatment for hair loss for at least 4 weeks and any systemic treatment for at least 3 months, before they participated in the study.
- •6)History of alcohol or drug addiction.
- •7)Subjects using other marketed hair fall control and/or hair growth products during the study period.
- •8)Subjects who have plans of shaving scalp hair during the study
- •9)Subjects who are on chronic oral steroids 03 months before initial application and during the study period.
- •10)History or present condition of irritated or visibly inflamed scalp or severe scalp disease.
- •11)Subjects having a history or present condition of an allergic response to any cosmetic products.
- •12)Any other condition which could warrant exclusion from the study, as per the dermatologist’s/investigator’s discretion.
- •13)Pregnant or breastfeeding or planning to become pregnant during the study period.
- •14)History of chronic illness which may influence the cutaneous state.
- •15)Subjects participating in other similar cosmetics, devices or therapeutic trials or hair/scalp care products within the last four weeks.
研究者
相似试验
已完成
4 期
A Clinical Study in Adult SmokersCTRI/2018/08/015253Dabur International Limited30
已完成
4 期
A Clinical Study in Subjects with Dental Hyper-SensitivityCTRI/2018/08/015259Dabur International Limited30
尚未招募
不适用
Safety and Efficacy of Dysmegesic in the management of Menstrual Pain in Female Subjects.CTRI/2021/01/030354Shield Healthcare Pvt Ltd
尚未招募
2 期
A Clinical trail on Parangipattai chooranam in the management of Azhal keel vaayu (Osteoarthritis of Knee) among patients attending OPD and IPD of Government Siddha Medical College and Hospital, PalayamkottaiCTRI/2024/06/068546Government Siddha Medical College and Hospital
尚未招募
3 期
This is a clinical study to evaluate efficacy and safety of human normal immunoglobulin for intravenous administration in adult patients with chronic primary immune thrombocytopenia.CTRI/2023/07/055259Intas Pharmaceuticals Limited, India